151 related articles for article (PubMed ID: 9040027)
1. Is CD36 deficiency an etiology of hereditary hypertrophic cardiomyopathy?
Tanaka T; Sohmiya K; Kawamura K
J Mol Cell Cardiol; 1997 Jan; 29(1):121-7. PubMed ID: 9040027
[TBL] [Abstract][Full Text] [Related]
2. CD36 deficiency has little influence on the pathophysiology of hypertrophic cardiomyopathy.
Nakamura T; Sugihara H; Inaba T; Kinoshita N; Adachi Y; Hirasaki S; Matsuo A; Azuma A; Nakagawa M
J Mol Cell Cardiol; 1999 Jun; 31(6):1253-9. PubMed ID: 10371699
[TBL] [Abstract][Full Text] [Related]
3. [Malignant familial cardiomyopathy with sudden death, typical asymmetric septal hypertrophy and dilated cardiomyopathy-like features].
Seo T; Yokota Y; Maehashi N; Takarada A; Kubo M; Toh S; Nakanishi O; Masuda J; Fujitani K; Fukuzaki H
J Cardiogr; 1986 Mar; 16(1):81-94. PubMed ID: 3782892
[TBL] [Abstract][Full Text] [Related]
4. [Hypertrophic cardiomyopathy manifesting different modes of illness: report of three cases].
Shida M; Miyazaki Y; Matsuyama K; Iwami G; Ooga M; Chiba M; Furuta Y; Toshima H; Koga Y
J Cardiol; 1987 Mar; 17(1):187-97. PubMed ID: 3429921
[TBL] [Abstract][Full Text] [Related]
5. CD36 abnormality and impaired myocardial long-chain fatty acid uptake in patients with hypertrophic cardiomyopathy.
Okamoto F; Tanaka T; Sohmiya K; Kawamura K
Jpn Circ J; 1998 Jul; 62(7):499-504. PubMed ID: 9707006
[TBL] [Abstract][Full Text] [Related]
6. [Molecular aspects of cardiac hypertrophy and their implications in cardiomyopathies].
Kimura A
Nihon Rinsho; 2000 Jan; 58(1):223-7. PubMed ID: 10885318
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
[TBL] [Abstract][Full Text] [Related]
8. [Different patterns of 123I-BMIPP myocardial accumulation in patients with type I and II CD36 deficiency].
Watanabe K; Toba K; Ogawa Y; Aizawa Y; Tanabe N; Miyajima S; Kusano Y; Nagatomo T; Hirokawa Y
Kaku Igaku; 1997 Dec; 34(12):1125-30. PubMed ID: 9494334
[TBL] [Abstract][Full Text] [Related]
9. Inherited and de novo mutations in the cardiac actin gene cause hypertrophic cardiomyopathy.
Olson TM; Doan TP; Kishimoto NY; Whitby FG; Ackerman MJ; Fananapazir L
J Mol Cell Cardiol; 2000 Sep; 32(9):1687-94. PubMed ID: 10966831
[TBL] [Abstract][Full Text] [Related]
10. [Secondary atypical hypertrophy: hypertrophic cardiomyopathy with acquired risk factors (author's transl)].
Koga Y; Itaya K; Toshima H
J Cardiogr; 1981 Dec; 11(4):1063-75. PubMed ID: 7201489
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Van Driest SL; Jaeger MA; Ommen SR; Will ML; Gersh BJ; Tajik AJ; Ackerman MJ
J Am Coll Cardiol; 2004 Aug; 44(3):602-10. PubMed ID: 15358028
[TBL] [Abstract][Full Text] [Related]
12. [Unclassified cardiomyopathies: subspecies and their transformation].
Ikeda Y; Kawai S; Okada R; Yamaguchi H
J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
[TBL] [Abstract][Full Text] [Related]
13. [Hypertrophic cardiomyopathy showing no 123I-BMIPP myocardial accumulation with type I CD36 deficiency].
Watanabe K; Miyajima S; Kusano Y; Tanabe N; Hirokawa Y
Kaku Igaku; 1997 Jul; 34(7):481-6. PubMed ID: 9293711
[TBL] [Abstract][Full Text] [Related]
14. Inflammatory dilated cardiomyopathy (DCMI).
Maisch B; Richter A; Sandmöller A; Portig I; Pankuweit S;
Herz; 2005 Sep; 30(6):535-44. PubMed ID: 16170686
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype.
Kubo T; Gimeno JR; Bahl A; Steffensen U; Steffensen M; Osman E; Thaman R; Mogensen J; Elliott PM; Doi Y; McKenna WJ
J Am Coll Cardiol; 2007 Jun; 49(25):2419-26. PubMed ID: 17599605
[TBL] [Abstract][Full Text] [Related]
16. Novel locus for an inherited cardiomyopathy maps to chromosome 7.
Song L; DePalma SR; Kharlap M; Zenovich AG; Cirino A; Mitchell R; McDonough B; Maron BJ; Seidman CE; Seidman JG; Ho CY
Circulation; 2006 May; 113(18):2186-92. PubMed ID: 16651466
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathy with type I CD36 deficiency.
Watanabe K; Toba K; Ogawa Y; Kodama M; Hirono S; Ohkura Y; Hanawa H; Nakamura Y; Aoki Y; Fuse I; Aizawa Y; Miyajima S; Kusano Y; Nagatomo T; Hasegawa G; Naito M
Jpn Circ J; 1998 Jul; 62(7):541-2. PubMed ID: 9707013
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of the risk of sudden death in hypertrophic cardiomyopathy].
Sadoul N; de Chillou C; Aliot E; McKenna WJ
Arch Mal Coeur Vaiss; 1999 Apr; 92 Spec No 1():65-73. PubMed ID: 10326160
[TBL] [Abstract][Full Text] [Related]
19. Amyloid heart disease mimicking hypertrophic cardiomyopathy.
Mörner S; Hellman U; Suhr OB; Kazzam E; Waldenström A
J Intern Med; 2005 Sep; 258(3):225-30. PubMed ID: 16115295
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of development of asymmetric septal hypertrophy in patients with essential systemic hypertension.
Yokota Y; Teng SS; Emoto R; Miki T; Takarada A; Seo T; Sano H; Fukuzaki H
Jpn Circ J; 1989 Oct; 53(10):1173-84. PubMed ID: 2533275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
